What is the current annual EBITDA of RDY?

As of today, RDY annual EBITDA is $762.92M

What is 1-year change in RDY annual EBITDA?

RDY annual EBITDA is down -25.48% year-over-year

What is 3-year change in RDY annual EBITDA?

RDY annual EBITDA is down -5.46% over the past 3 years

How far is RDY annual EBITDA from its all-time high?

RDY annual EBITDA is currently -25.48% below its historical high of $1.02B set on March 31, 2025

How does RDY annual EBITDA rank versus sector peers?

RDY annual EBITDA is higher than 92.10% of companies in Healthcare sector

When is RDY next annual earnings release?

As of today, the next annual earnings release for RDY has not been scheduled

What is the current quarterly EBITDA of RDY?

As of today, RDY quarterly EBITDA is $180.44M

What is RDY quarterly EBITDA most recent change?

RDY quarterly EBITDA was up +103.29% on September 30, 2026

What is 1-year change in RDY quarterly EBITDA?

RDY quarterly EBITDA is down -23.36% year-over-year

How far is RDY quarterly EBITDA from its all-time high?

RDY quarterly EBITDA is currently -33.96% below its historical high of $273.22M set on December 31, 2024

How does RDY quarterly EBITDA rank versus sector peers?

RDY quarterly EBITDA is higher than 91.05% of companies in Healthcare sector

When is RDY next earnings release?

The next earnings release for RDY is on January 21, 2027

What is the current TTM EBITDA of RDY?

As of today, RDY TTM EBITDA is $549.82M

What is RDY TTM EBITDA most recent change?

RDY TTM EBITDA was down -9.09% on September 30, 2026

What is 1-year change in RDY TTM EBITDA?

RDY TTM EBITDA is down -44.90% year-over-year

How far is RDY TTM EBITDA from its all-time high?

RDY TTM EBITDA is currently -46.26% below its historical high of $1.02B set on March 31, 2025

How does RDY TTM EBITDA rank versus sector peers?

RDY TTM EBITDA is higher than 90.34% of companies in Healthcare sector

When is RDY next earnings release?

The next earnings release for RDY is on January 21, 2027

RDY EBITDA History & Chart Since 1995

Annual EBITDA

$762.92M$260.88M-25.48%

March 31, 2026

Summary

Current Value: As of today, RDY annual EBITDA is $762.92M, down -25.48% on March 31, 2026
Historical Performance: RDY annual EBITDA is down -5.46% over the past 3 years, up +26.35% over the past 5 years
All-Time High Comparison: RDY annual EBITDA is currently -25.48% below its historical high of $1.02B set on March 31, 2025
3-Year Low Comparison: RDY annual EBITDA is at its 3-year low
Sector Comparison: RDY annual EBITDA is higher than 92.10% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

RDY Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Mar 31, 26	$762.92M	-25.5%	-5.5%	+26.4%	+121.7%
Quarterly EBITDA	Sep 30, 26	$180.44M	-23.4%	-18.6%	+0.1%	+74.2%
TTM EBITDA	Sep 30, 26	$549.82M	-44.9%	-39.9%	-7.6%	+48.2%
Price	Nov 6, 26	$14.91	+10.7%	+15.2%	+17.6%	+127.4%
PE Ratio	Nov 6, 26	40.97	+148.4%	+134.8%	+2.5%	+91.0%
Annual Revenue	Mar 31, 26	$3.80B	-1.3%	+24.3%	+48.8%	+131.7%
Annual EPS	Mar 31, 26	$0.58	-27.4%	-13.7%	+108.5%	+103.9%
	Mar 31, 26	$525.62M	-36.1%	-19.1%	+21.8%	+107.8%
Annual Net Income	Mar 31, 26	$480.61M	-29.0%	-14.3%	+107.0%	+98.2%

EBITDA Highs

RDY Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$1.02B	Mar 31, 25	-25.5%
5Y	$1.02B	Mar 31, 25	-25.5%
All	$1.02B	Mar 31, 25	-25.5%

EBITDA Lows

RDY Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$762.92M	Mar 31, 26	at low
5Y	$603.81M	N/A	+26.4%
All	$11.77M	Mar 1, 97	+6379.5%

EBITDA History

Year	Value	Change
2026	$762.92M	-25.5%
2025	$1.02B	+7.7%
2024	$950.72M	+17.8%
2023	$806.96M	+29.8%
2022	$621.49M	+2.9%
2021	$603.81M	+4.1%
2020	$579.77M	+27.6%
2019	$454.29M	+27.9%
2018	$355.10M	-1.4%
2017	$360.22M	-39.6%
2016	$596.54M	+7.3%
2015	$555.71M	+7.9%
2014	$514.90M	+11.9%
2013	$459.95M	-7.3%
2012	$495.93M	+44.1%
2011	$344.09M	+12.9%

Year	Value	Change
2010	$304.89M	-3.2%
2009	$315.07M	+53.4%
2008	$205.39M	-44.0%
2007	$366.87M	+405.9%
2006	$72.52M	+118.9%
2005	$33.13M	-49.6%
2004	$65.70M	-28.9%
2003	$92.35M	-26.2%
2002	$125.17M	+128.3%
2001	$54.83M	+129.1%
2000	$23.93M	+30.3%
1999	$18.37M	-8.7%
1998	$20.13M	+71.0%
1997	$11.77M	-13.1%
1996	$13.55M	+3.4%
1995	$13.11M	-

FAQ

What is the current annual EBITDA of RDY?: As of today, RDY annual EBITDA is $762.92M
What is 1-year change in RDY annual EBITDA?: RDY annual EBITDA is down -25.48% year-over-year
What is 3-year change in RDY annual EBITDA?: RDY annual EBITDA is down -5.46% over the past 3 years
How far is RDY annual EBITDA from its all-time high?: RDY annual EBITDA is currently -25.48% below its historical high of $1.02B set on March 31, 2025
How does RDY annual EBITDA rank versus sector peers?: RDY annual EBITDA is higher than 92.10% of companies in Healthcare sector
When is RDY next annual earnings release?: As of today, the next annual earnings release for RDY has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$180.44M$91.68M+103.29%

September 30, 2026

Summary

Current Value: As of today, RDY quarterly EBITDA is $180.44M, up +103.29% on September 30, 2026
Historical Performance: RDY quarterly EBITDA is down -23.36% year-over-year, down -18.56% over the past 3 years
All-Time High Comparison: RDY quarterly EBITDA is currently -33.96% below its historical high of $273.22M set on December 31, 2024
3-Year Low Comparison: RDY quarterly EBITDA is +168.78% above its 3-year low of $67.14M reached on March 31, 2026
Sector Comparison: RDY quarterly EBITDA is higher than 91.05% of companies in Healthcare sector

Performance

RDY Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$180.44M	+103.3%	-23.4%	-18.6%	+0.1%
Annual EBITDA	Mar 31, 26	$762.92M	–	-25.5%	-5.5%	+26.4%
TTM EBITDA	Sep 30, 26	$549.82M	-9.1%	-44.9%	-39.9%	-7.6%
Price	Nov 6, 26	$14.91	+23.1%	+10.7%	+15.2%	+17.6%
PE Ratio	Nov 6, 26	40.97	+50.6%	+148.4%	+134.8%	+2.5%
Quarterly Revenue	Sep 30, 26	$907.22M	+6.4%	-10.1%	+9.0%	+16.6%
Quarterly EPS	Sep 30, 26	$0.12	+106.6%	-41.2%	-46.0%	-27.9%
	Sep 30, 26	$124.45M	+288.5%	-29.9%	-29.2%	-11.1%
Quarterly Net Income	Sep 30, 26	$95.57M	+108.1%	-41.5%	-46.6%	-28.6%

Quarterly EBITDA Highs

RDY Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$235.43M	N/A	-23.4%
3Y	$273.22M	Dec 31, 24	-34.0%
5Y	$273.22M	Dec 31, 24	-34.0%
All	$273.22M	Dec 31, 24	-34.0%

Quarterly EBITDA Lows

RDY Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$67.14M	Mar 31, 26	+168.8%
3Y	$67.14M	Mar 31, 26	+168.8%
5Y	$67.14M	Mar 31, 26	+168.8%
All	$1.46M	Mar 31, 04	>+9999.0%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$180.44M	+103.3%
Jun 2026	$88.76M	+32.2%
Mar 2026	$67.14M	-68.6%
Dec 2025	$213.48M	-9.3%
Sep 2025	$235.43M	-6.7%
Jun 2025	$252.46M	+6.7%
Mar 2025	$236.71M	-13.4%
Dec 2024	$273.22M	+6.2%
Sep 2024	$257.18M	+0.5%
Jun 2024	$255.96M	+19.1%
Mar 2024	$214.87M	-11.7%
Dec 2023	$243.34M	+9.8%
Sep 2023	$221.55M	-11.2%
Jun 2023	$249.55M	+29.7%
Mar 2023	$192.46M	-23.4%
Dec 2022	$251.13M	+5.8%
Sep 2022	$237.37M	+96.8%
Jun 2022	$120.61M	-22.5%
Mar 2022	$155.53M	-3.4%
Dec 2021	$160.99M	-10.7%
Sep 2021	$180.28M	+46.6%
Jun 2021	$123.01M	-11.0%
Mar 2021	$138.28M	-9.7%
Dec 2020	$153.18M	-7.0%
Sep 2020	$164.68M	+12.0%
Jun 2020	$146.97M	+13.2%
Mar 2020	$129.82M	-9.6%
Dec 2019	$143.53M	-28.4%
Sep 2019	$200.39M	+90.6%
Jun 2019	$105.16M	-9.6%
Mar 2019	$116.28M	+2.3%
Dec 2018	$113.71M	+6.9%
Sep 2018	$106.36M	-6.4%
Jun 2018	$113.63M	+32.7%
Mar 2018	$85.62M	-28.5%
Dec 2017	$119.78M	+16.4%
Sep 2017	$102.91M	+117.0%
Jun 2017	$47.43M	-42.1%
Mar 2017	$81.95M	-34.7%
Dec 2016	$125.44M	+40.8%
Sep 2016	$89.10M	+58.3%
Jun 2016	$56.29M	-51.3%
Mar 2016	$115.48M	-24.1%
Dec 2015	$152.14M	-12.7%
Sep 2015	$174.37M	+12.3%
Jun 2015	$155.30M	+17.5%
Mar 2015	$132.17M	-13.2%
Dec 2014	$152.32M	+13.9%
Sep 2014	$133.77M	-2.0%
Jun 2014	$136.45M	+10.5%
Mar 2014	$123.50M	-21.7%

Month	Value	Change
Dec 2013	$157.71M	+19.9%
Sep 2013	$131.48M	+36.7%
Jun 2013	$96.15M	-28.6%
Mar 2013	$134.64M	+27.7%
Dec 2012	$105.45M	-16.1%
Sep 2012	$125.69M	+37.4%
Jun 2012	$91.49M	-29.0%
Mar 2012	$128.94M	-23.9%
Dec 2011	$169.51M	+63.6%
Sep 2011	$103.58M	+20.5%
Jun 2011	$85.93M	-11.4%
Mar 2011	$97.01M	+14.8%
Dec 2010	$84.47M	-4.0%
Sep 2010	$87.96M	+17.7%
Jun 2010	$74.72M	+17.4%
Mar 2010	$63.63M	-19.4%
Dec 2009	$78.91M	+15.0%
Sep 2009	$68.61M	-23.6%
Jun 2009	$89.85M	-31.0%
Mar 2009	$130.31M	+92.4%
Dec 2008	$67.72M	+31.1%
Sep 2008	$51.64M	+12.0%
Jun 2008	$46.12M	+24.6%
Mar 2008	$37.03M	-17.7%
Dec 2007	$44.98M	-3.3%
Sep 2007	$46.52M	-23.5%
Jun 2007	$60.85M	-53.9%
Mar 2007	$131.88M	+103.9%
Dec 2006	$64.67M	-35.8%
Sep 2006	$100.76M	+93.5%
Jun 2006	$52.07M	+177.6%
Mar 2006	$18.76M	+30.6%
Dec 2005	$14.36M	-68.5%
Sep 2005	$45.63M	+125.0%
Jun 2005	$20.28M	+232.0%
Mar 2005	$6.11M	+177.8%
Dec 2004	$2.20M	-73.7%
Sep 2004	$8.36M	-52.0%
Jun 2004	$17.42M	+1,090.2%
Mar 2004	$1.46M	-90.8%
Dec 2003	$15.86M	-35.8%
Sep 2003	$24.70M	+4.5%
Jun 2003	$23.63M	+31.7%
Mar 2003	$17.94M	-0.3%
Dec 2002	$17.99M	-22.7%
Sep 2002	$23.27M	-26.2%
Jun 2002	$31.55M	+39.0%
Mar 2002	$22.70M	-36.2%
Dec 2001	$35.59M	-31.0%
Sep 2001	$51.60M	+225.7%
Jun 2001	$15.84M	-

FAQ

What is the current quarterly EBITDA of RDY?: As of today, RDY quarterly EBITDA is $180.44M
What is RDY quarterly EBITDA most recent change?: RDY quarterly EBITDA was up +103.29% on September 30, 2026
What is 1-year change in RDY quarterly EBITDA?: RDY quarterly EBITDA is down -23.36% year-over-year
How far is RDY quarterly EBITDA from its all-time high?: RDY quarterly EBITDA is currently -33.96% below its historical high of $273.22M set on December 31, 2024
How does RDY quarterly EBITDA rank versus sector peers?: RDY quarterly EBITDA is higher than 91.05% of companies in Healthcare sector
When is RDY next earnings release?: The next earnings release for RDY is on January 21, 2027

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$549.82M$54.99M-9.09%

September 30, 2026

Summary

Current Value: As of today, RDY TTM EBITDA is $549.82M, down -9.09% on September 30, 2026
Historical Performance: RDY TTM EBITDA is down -44.90% year-over-year, down -39.89% over the past 3 years
All-Time High Comparison: RDY TTM EBITDA is currently -46.26% below its historical high of $1.02B set on March 31, 2025
3-Year Low Comparison: RDY TTM EBITDA is at its 3-year low
Sector Comparison: RDY TTM EBITDA is higher than 90.34% of companies in Healthcare sector

Performance

RDY Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$549.82M	-9.1%	-44.9%	-39.9%	-7.6%
Annual EBITDA	Mar 31, 26	$762.92M	–	-25.5%	-5.5%	+26.4%
Quarterly EBITDA	Sep 30, 26	$180.44M	+103.3%	-23.4%	-18.6%	+0.1%
Price	Nov 6, 26	$14.91	+23.1%	+10.7%	+15.2%	+17.6%
PE Ratio	Nov 6, 26	40.97	+50.6%	+148.4%	+134.8%	+2.5%
TTM Revenue	Sep 30, 26	$3.56B	-2.8%	-10.5%	+9.8%	+28.9%
TTM EPS	Sep 30, 26	$0.36	-18.2%	-55.5%	-51.0%	+14.8%
	Sep 30, 26	$317.64M	-14.3%	-58.5%	-57.5%	-25.8%
TTM Net Income	Sep 30, 26	$299.10M	-18.5%	-55.9%	-51.6%	+13.4%

TTM EBITDA Highs

RDY TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$997.83M	N/A	-44.9%
3Y	$1.02B	Mar 31, 25	-46.3%
5Y	$1.02B	Mar 31, 25	-46.3%
All	$1.02B	Mar 31, 25	-46.3%

TTM EBITDA Lows

RDY TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$549.82M	Sep 30, 26	at low
3Y	$549.82M	Sep 30, 26	at low
5Y	$549.82M	Sep 30, 26	at low
All	$15.84M	Jun 30, 01	+3370.3%

TTM EBITDA History

Month	Value	Change
Sep 2026	$549.82M	-9.1%
Jun 2026	$604.81M	-21.3%
Mar 2026	$768.51M	-18.1%
Dec 2025	$938.08M	-6.0%
Sep 2025	$997.83M	-2.1%
Jun 2025	$1.02B	-0.3%
Mar 2025	$1.02B	+2.2%
Dec 2024	$1.00B	+3.1%
Sep 2024	$971.34M	+3.8%
Jun 2024	$935.72M	+0.7%
Mar 2024	$929.30M	+2.5%
Dec 2023	$906.89M	-0.9%
Sep 2023	$914.69M	-1.7%
Jun 2023	$930.50M	+16.1%
Mar 2023	$801.56M	+4.8%
Dec 2022	$764.63M	+13.4%
Sep 2022	$674.49M	+9.2%
Jun 2022	$617.40M	-0.4%
Mar 2022	$619.81M	+2.9%
Dec 2021	$602.56M	+1.3%
Sep 2021	$594.76M	+2.7%
Jun 2021	$579.16M	-4.0%
Mar 2021	$603.12M	+1.4%
Dec 2020	$594.65M	+1.6%
Sep 2020	$585.00M	-5.8%
Jun 2020	$620.71M	+7.2%
Mar 2020	$578.90M	+2.4%
Dec 2019	$565.36M	+5.6%
Sep 2019	$535.54M	+21.3%
Jun 2019	$441.51M	-1.9%
Mar 2019	$449.98M	+7.3%
Dec 2018	$419.32M	-1.4%
Sep 2018	$425.39M	+0.8%
Jun 2018	$421.94M	+18.6%
Mar 2018	$355.74M	+1.0%
Dec 2017	$352.08M	-1.6%
Sep 2017	$357.73M	+4.0%
Jun 2017	$343.93M	-2.5%
Mar 2017	$352.79M	-8.7%
Dec 2016	$386.32M	-6.5%
Sep 2016	$413.01M	-17.1%
Jun 2016	$498.28M	-16.6%
Mar 2016	$597.28M	-2.7%
Dec 2015	$613.97M	-0.0%
Sep 2015	$614.15M	+7.1%
Jun 2015	$573.55M	+3.4%
Mar 2015	$554.71M	+1.6%
Dec 2014	$546.04M	-1.0%
Sep 2014	$551.43M	+0.4%
Jun 2014	$549.14M	+7.9%
Mar 2014	$508.84M	-2.1%

Month	Value	Change
Dec 2013	$519.98M	+11.2%
Sep 2013	$467.72M	+1.3%
Jun 2013	$461.94M	+1.0%
Mar 2013	$457.27M	+1.3%
Dec 2012	$451.56M	-12.4%
Sep 2012	$515.62M	+4.5%
Jun 2012	$493.52M	+1.1%
Mar 2012	$487.96M	+7.0%
Dec 2011	$456.03M	+22.9%
Sep 2011	$371.00M	+4.4%
Jun 2011	$355.38M	+3.3%
Mar 2011	$344.17M	+10.7%
Dec 2010	$310.79M	+1.8%
Sep 2010	$305.22M	+6.8%
Jun 2010	$285.86M	-5.0%
Mar 2010	$300.99M	-18.1%
Dec 2009	$367.67M	+3.1%
Sep 2009	$356.48M	+5.0%
Jun 2009	$339.52M	+14.8%
Mar 2009	$295.79M	+46.1%
Dec 2008	$202.51M	+12.6%
Sep 2008	$179.77M	+2.9%
Jun 2008	$174.65M	-7.8%
Mar 2008	$189.38M	-33.4%
Dec 2007	$284.24M	-6.5%
Sep 2007	$303.93M	-15.1%
Jun 2007	$358.16M	+2.5%
Mar 2007	$349.38M	+47.9%
Dec 2006	$236.26M	+27.1%
Sep 2006	$185.95M	+42.1%
Jun 2006	$130.82M	+32.1%
Mar 2006	$99.03M	+14.6%
Dec 2005	$86.38M	+16.4%
Sep 2005	$74.22M	+100.9%
Jun 2005	$36.95M	+8.4%
Mar 2005	$34.10M	+15.8%
Dec 2004	$29.45M	-31.7%
Sep 2004	$43.11M	-27.5%
Jun 2004	$59.45M	-9.4%
Mar 2004	$65.65M	-20.1%
Dec 2003	$82.13M	-2.5%
Sep 2003	$84.25M	+1.7%
Jun 2003	$82.83M	-8.7%
Mar 2003	$90.75M	-5.0%
Dec 2002	$95.51M	-15.6%
Sep 2002	$113.11M	-20.0%
Jun 2002	$141.44M	+12.5%
Mar 2002	$125.73M	+22.0%
Dec 2001	$103.03M	+52.8%
Sep 2001	$67.44M	+325.7%
Jun 2001	$15.84M	-

FAQ

What is the current TTM EBITDA of RDY?: As of today, RDY TTM EBITDA is $549.82M
What is RDY TTM EBITDA most recent change?: RDY TTM EBITDA was down -9.09% on September 30, 2026
What is 1-year change in RDY TTM EBITDA?: RDY TTM EBITDA is down -44.90% year-over-year
How far is RDY TTM EBITDA from its all-time high?: RDY TTM EBITDA is currently -46.26% below its historical high of $1.02B set on March 31, 2025
How does RDY TTM EBITDA rank versus sector peers?: RDY TTM EBITDA is higher than 90.34% of companies in Healthcare sector
When is RDY next earnings release?: The next earnings release for RDY is on January 21, 2027

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

RDY Official Website www.drreddys.com
RDY Profile on Yahoo Finance finance.yahoo.com/quote/RDY
RDY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rdy